Last updated: December 2024
Pertussis is a highly contagious infection of the respiratory tract caused by the bacterium Bordetella pertussis.
It is transmitted via airborne droplets spread by infected people (by coughing and/or sneezing), particularly within 3 weeks of the onset of cough
[1]
Citation
1.
Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec. 2015;(35):433-458. https://iris.who.int/bitstream/handle/10665/242413/WER9035_433-458.PDF [Accessed May 17, 2024].
. Despite the development of effective vaccines, it remains an important cause of morbidity and mortality, particularly in infants.
This disease is endemic worldwide and outbreaks are common. It most commonly affects children < 5 years, but can affect any age group. Reported incidence in adolescents and adults has been increasing in some regions
[2]
Citation
2.
Güris D, Strebel PM, Bardenheier B, et al. Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996. Clin Infect Dis. 1999;28(6):1230-1237.
https://doi.org/10.1086/514776 [Accessed September 10, 2024].
.
Pertussis is a notifiable disease in many countries, and cases should be reported to local or national public health authorities. Pertussis immunization is part of all vaccination schedules and is included in the Expanded Programme on Immunization (EPI).
Clinical features
After an incubation period of 7 to 10 days (up to 21 days), the illness evolves in 3 stages
[3]
Citation
3.
Daniels HL, Sabella C. Bordetella pertussis (Pertussis). Pediatr Rev. 2018;39(5):247-257.
https://doi.org/10.1542/pir.2017-0229 [Accessed September 11, 2024].
:
- Catarrhal stage (1 to 2 weeks, but may be shorter in infants < 6 months):
- Runny nose, mild cough, no or low-grade fever.
- During this stage, the disease is indistinguishable from other non-specific respiratory infections.
- Paroxysmal stage (1 to 6 weeks):
- Cough of increasing severity, occuring in characteristic bouts (paroxysms) of a series of coughs during one exhalation, followed by a laboured inspiration causing a distinctive gasping sound (whoop), and/or post-tussive vomiting.
- No or low-grade fever.
- Apnoea and cyanosis (in infants).
- Prolonged cough, sometimes without paroxysms or whoop (particularly in older children and adults).
Complications may include secondary bacterial pneumonia (new-onset fever can be an indicator), dehydration and malnutrition triggered by feeding difficulty due to cough and vomiting, seizures, encephalopathy, sudden death, intracranial bleeding, petechiae, rib fracture, hernia, rectal prolapse.
- Convalescent stage (weeks to months):
- Paroxysms of cough gradually decrease in frequency and severity.
The disease is most severe, with a high risk of death, in infants. Adolescents and adults commonly have milder symptoms, but older adults, immunocompromised persons, and people with underlying respiratory conditions are at risk of severe disease and hospitalisation
[4]
Citation
4.
Mbayei SA, Faulkner A, Miner C, et al. Severe Pertussis Infections in the United States, 2011–2015. Clin Infect Dis. 2019;69(2):218-226.
https://doi.org/10.1093/cid/ciy889 [Accessed September 13, 2024]
.
Pertussis is most contagious and antibiotic treatment is most beneficial during the catarrhal stage of the illness. Since this is also the period during which clinical symptoms and signs are non-specific, it is necessary to maintain a high index of suspicion with clues from the context. These include patients with any compatible symptoms and close contact with a suspected case or in a pertussis outbreak setting.
Management
Suspected cases
Antibiotic treatment
Antibiotic treatment is indicated for the following patients
[5]
Citation
5.
Centers for Disease Control and Prevention. For Clinicians: Pertussis Treatment. Published online August 4, 2022.
https://www.cdc.gov/pertussis/clinical/treatment.html [Accessed April 28, 2024].
and should be started as soon as pertussis is suspected:
- All patients 1 year of age and older, within 3 weeks of the onset of cough.
- Infants and pregnant women, within 6 weeks of the onset of cough.
First line | |
---|---|
azithromycin PO for 5 days |
|
Alternatives | |
erythromycin PO
(a)
Citation
a.
Erythromycin is an alternative, but azithromycin is better tolerated and simpler to administer (shorter treatment duration, fewer daily doses).
for 7 days |
|
co-trimoxazole PO
(b)
Citation
b.
Use co-trimoxazole only if macrolides are contra-indicated, not tolerated, or not available. Avoid: - during the first trimester of pregnancy (risk of congenital malformations), - after 36 weeks of pregnancy and in women breastfeeding neonates (0 to 4 weeks), or breastfeeding infants that are premature, low birth weight, jaundiced, or ill (risk of haemolysis and jaundice in the child). Advise patients to seek immediate medical attention if there are signs of anaemia or jaundice, especially in regions with high prevalence of G6PD deficiency. for 14 days |
|
Admit the following patients to hospital
- Patients with severe illness (e.g. respiratory distress, apnoea, cyanosis, pneumonia, seizures or impaired consciousness)
- Infants up to 3 months of age (with monitoring 24 hours per day due to the risk of apnoea)
- Patients with difficulty in feeding or drinking
Infection prevention and control measures
Patients with pertussis are considered infectious until they have completed 5 days of appropriate antibiotics, or if not treated, until 21 days after the start of the paroxysmal cough [1] Citation 1. Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec. 2015;(35):433-458. https://iris.who.int/bitstream/handle/10665/242413/WER9035_433-458.PDF [Accessed May 17, 2024]. . During this infectious period, these measures should be followed:
- In hospital: single room if possible, or grouping pertussis cases together away from other patients (cohorting); standard precautions and droplet precautions (including, for the patient, cough etiquette and wearing a surgical mask if outside the room)
[6]
Citation
6.
Siegel J, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Published online July 2023.
https://www.cdc.gov/infection-control/media/pdfs/Guideline-Isolation-H.pdf [Accessed April 28,2024]. - All patients: avoid contact with young children and pregnant women; avoid congregate settings including childcare, school, and work
Supportive care
Hydration and nutrition: if child is breastfeeding, continue; ensure adequate fluid and calorie intake, give frequent small feedings including after coughing bouts and post-tussive vomiting; some patients may require nasogastric tube feeding or IV maintenance fluids; be aware that NG tube placement might provoke paroxysmal coughing, so it should be inserted by experienced medical staff with minimal manipulation. If weight loss occurred during illness, consider food supplements for several weeks during convalescent stage when child is able to eat comfortably.
Respiratory measures
- Place the patient in a semi-reclining position (± 30°).
- In case of apnoea, stimulate the patient, but be prepared to ventilate if necessary (keep bag and mask accessible).
- Administer oxygen if SpO2 < 92%, for severe respiratory distress, or for recurrent apnoea. Perform gentle oropharyngeal suctioning if required but avoid deep suctioning (may provoke paroxysmal coughing).
For children treated as outpatients, teach the parents about signs that require immediate medical attention (e.g. respiratory difficulty, apnoea, cyanosis, increasing fever, seizures or impaired consciousness, dehydration, feeding difficulty).
Contacts
- Post-exposure prophylaxis (same antibiotic treatment as for suspect cases) is recommended, regardless of vaccination status, for:
- Asymptomatic close contacts (having face-to-face exposure or direct contact with oral, nasal, or other respiratory secretions
[7]
Citation
7.
World Health Organization. Pertussis: Vaccine-Preventable Diseases Surveillance Standards. Published online September 5, 2018.
https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-pertussis [Accessed May 19, 2024]. ) of a person with suspected pertussis within 3 weeks of onset of paroxysmal cough - Asymptomatic exposed people at high risk of complications or who will come into contact with people at high risk
[4]
Citation
4.
Mbayei SA, Faulkner A, Miner C, et al. Severe Pertussis Infections in the United States, 2011–2015. Clin Infect Dis. 2019;69(2):218-226.
https://doi.org/10.1093/cid/ciy889 [Accessed September 13, 2024] [8] Citation 8. Centers for Disease Control and Prevention. Pertussis and Postexposure Antimicrobial Prophylaxis (PEP). Published online August 4, 2022.
https://www.cdc.gov/pertussis/php/postexposure-prophylaxis/index.html [Accessed April 29, 2024]. :- pregnant women in the third trimester (risk to neonate),
- infants under 1 year,
- people with immunodepression, moderate to severe asthma, and consider for people with other underlying respiratory conditions and adults ≥ 65 years.
- Asymptomatic close contacts (having face-to-face exposure or direct contact with oral, nasal, or other respiratory secretions
[7]
Citation
7.
World Health Organization. Pertussis: Vaccine-Preventable Diseases Surveillance Standards. Published online September 5, 2018.
- Isolation of asymptomatic contacts is not necessary.
- Symptomatic contacts should be treated as suspected pertussis.
- Assess whether the person is up-to-date with pertussis vaccination according to national protocol (see Prevention).
Prevention
- Pertussis vaccination provides substantial immunity that wanes over time [1] Citation 1. Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec. 2015;(35):433-458. https://iris.who.int/bitstream/handle/10665/242413/WER9035_433-458.PDF [Accessed May 17, 2024]. .
- In all cases (suspected cases and contacts) who are not up-to-date with pertussis vaccination, begin or refer for vaccination.
- Routine vaccination with a 3-dose primary series of polyvalent vaccine containing pertussis antigen(s) from the age of 6 weeks or according to national protocol. A booster dose is recommended, preferably during the second year of life [1] Citation 1. Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec. 2015;(35):433-458. https://iris.who.int/bitstream/handle/10665/242413/WER9035_433-458.PDF [Accessed May 17, 2024]. . Based on local epidemiology, further booster doses may be required later in life to reinforce immunity and reduce the risk of developing pertussis.
- If the pertussis primary vaccination series has been interrupted, it should be completed rather than restarted from the beginning.
- In general, vaccinations are deferred for patients with moderate to severe illness, but the vaccine should be administered as soon as the patient's condition has improved.
- Vaccination will probably not prevent disease in a person who is already infected by B. pertussis. It is not a substitute for post-exposure prophylaxis
[7]
Citation
7.
World Health Organization. Pertussis: Vaccine-Preventable Diseases Surveillance Standards. Published online September 5, 2018.
https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-pertussis [Accessed May 19, 2024]. [9] Citation 9. Blain A, Skoff T, Cassiday P, Tondella ML, Acosta A. Pertussis. In: Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention; 2020:Chapter 10.
https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-10-pertussis.html [Accessed May 19, 2024]. .
- (a)Erythromycin is an alternative, but azithromycin is better tolerated and simpler to administer (shorter treatment duration, fewer daily doses).
- (b)Use co-trimoxazole only if macrolides are contra-indicated, not tolerated, or not available.
Avoid:
- during the first trimester of pregnancy (risk of congenital malformations),
- after 36 weeks of pregnancy and in women breastfeeding neonates (0 to 4 weeks), or breastfeeding infants that are premature, low birth weight, jaundiced, or ill (risk of haemolysis and jaundice in the child).
Advise patients to seek immediate medical attention if there are signs of anaemia or jaundice, especially in regions with high prevalence of G6PD deficiency.
- 1. Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec. 2015;(35):433-458. https://iris.who.int/bitstream/handle/10665/242413/WER9035_433-458.PDF [Accessed May 17, 2024].
- 2.Güris D, Strebel PM, Bardenheier B, et al. Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996. Clin Infect Dis. 1999;28(6):1230-1237.
https://doi.org/10.1086/514776 [Accessed September 10, 2024]. - 3.Daniels HL, Sabella C. Bordetella pertussis (Pertussis). Pediatr Rev. 2018;39(5):247-257.
https://doi.org/10.1542/pir.2017-0229 [Accessed September 11, 2024]. - 4.
Mbayei SA, Faulkner A, Miner C, et al. Severe Pertussis Infections in the United States, 2011–2015. Clin Infect Dis. 2019;69(2):218-226.
https://doi.org/10.1093/cid/ciy889 [Accessed September 13, 2024] - 5.Centers for Disease Control and Prevention. For Clinicians: Pertussis Treatment. Published online August 4, 2022.
https://www.cdc.gov/pertussis/clinical/treatment.html [Accessed April 28, 2024]. - 6.Siegel J, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Published online July 2023.
https://www.cdc.gov/infection-control/media/pdfs/Guideline-Isolation-H.pdf [Accessed April 28,2024]. - 7.
World Health Organization. Pertussis: Vaccine-Preventable Diseases Surveillance Standards. Published online September 5, 2018.
https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-pertussis [Accessed May 19, 2024]. - 8.Centers for Disease Control and Prevention. Pertussis and Postexposure Antimicrobial Prophylaxis (PEP). Published online August 4, 2022.
https://www.cdc.gov/pertussis/php/postexposure-prophylaxis/index.html [Accessed April 29, 2024]. - 9.Blain A, Skoff T, Cassiday P, Tondella ML, Acosta A. Pertussis. In: Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention; 2020:Chapter 10.
https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-10-pertussis.html [Accessed May 19, 2024].